Local And International Research News
This is where interesting articals about new treatments/trials in MS will be placed.
Cannabis
The import of cannabis-based medicine Sativex from Canada for individual users has been approved by the Home Office, but as an unlicensed medicine.
Read full article here...
New drugs combo........
LONDON - Four years ago, 28-year-old multiple sclerosis patient Karen Ayres was wheelchair-bound and paralyzed. "I was trapped in a body that wouldn't do anything," she says. Now, following an experimental drug treatment, she has regained mobility and is studying for a doctoral degree.
Revimmune
TAMPA, Fla., July 31 (UPI) -- U.S. firm Accentia Biopharmaceuticals said Tuesday it is seeking the go-ahead for phase 3 testing of Revimmune, aimed at reversing multiple sclerosis.
Listen to the radio interview about Accentia
